Interconnection of Differentiated Thyroid Cancer and Cardiovascular Disease: Insulin Resistance as a Potential Molecular Link—A Proposed Mechanism - Top-Institutions - MDSpire

Interconnection of Differentiated Thyroid Cancer and Cardiovascular Disease: Insulin Resistance as a Potential Molecular Link—A Proposed Mechanism

By
Guizhang Hou
Tianshu Gao
April 22, 2026
0 min

Frontiers In Endocrinology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Endocrinology
- Oncology
- Cardiology
- Metabolic Research
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Oncology
- Endocrinology
- Cardio-Oncology
#3

Johns Hopkins University

Baltimore, MD
Key Differentiators
- Endocrinology
- Cardiology
- Oncology
- Metabolic Disease
#4

University of California, San Francisco (UCSF)

San Francisco, CA
Key Differentiators
- Endocrinology
- Oncology
- Cardiology
- Translational Medicine
#5

Massachusetts General Hospital

Boston, MA
Key Differentiators
- Endocrinology
- Cardiology
- Oncology
- Metabolic Research

Original Source(s)

Frontiers In Endocrinology

Interconnection of Differentiated Thyroid Cancer and Cardiovascular Disease: Insulin Resistance as a Potential Molecular Link—A Proposed Mechanism

by Guizhang Hou, Tianshu Gao
April 22, 2026

Related Content

Jama Network Open

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Frontiers In Medicine

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

by Xinhui Wang, Junyan Yu
May 28, 2026

Frontiers In Immunology

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study